Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein.
about
Evolutionary conserved close linkage of the c-fes/fps proto-oncogene and genetic sequences encoding a receptor-like proteinEAP, a highly conserved cellular protein associated with Epstein-Barr virus small RNAs (EBERs)Molecular cloning of the human B cell CD20 receptor predicts a hydrophobic protein with multiple transmembrane domainsAn Epstein-Barr virus transformation-associated membrane protein interacts with src family tyrosine kinasesOncogenes and RNA splicing of human tumor virusesGenetic diversity of EBV-encoded LMP1 in the Swiss HIV Cohort Study and implication for NF-Κb activationAnatomy of the herpes simplex virus 1 strain F glycoprotein B gene: primary sequence and predicted protein structure of the wild type and of monoclonal antibody-resistant mutantsComplex transcription of the Epstein-Barr virus BamHI fragment H rightward open reading frame 1 (BHRF1) in latently and lytically infected B lymphocytesEBV gene expression in an NPC-related tumour.Silencing of the Epstein-Barr virus latent membrane protein 1 gene by the Max-Mad1-mSin3A modulator of chromatin structureDistinctive charge configurations in proteins of the Epstein-Barr virus and possible functions.Genome rearrangements activate the Epstein-Barr virus gene whose product disrupts latency.Interaction of tumor necrosis factor receptor-associated factor signaling proteins with the latent membrane protein 1 PXQXT motif is essential for induction of epidermal growth factor receptor expressionEpstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element.Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2.Restricted expression of EBV latent genes and T-lymphocyte-detected membrane antigen in Burkitt's lymphoma cells.Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter.Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptorEpstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakiaIdentification of Epstein-Barr virus terminal protein 1 (TP1) in extracts of four lymphoid cell lines, expression in insect cells, and detection of antibodies in human seraA nuclear matrix attachment region organizes the Epstein-Barr viral plasmid in Raji cells into a single DNA domain.Novel transcription from the Epstein-Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma.Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule.The Epstein-Barr virus latent membrane protein 1 putative Janus kinase 3 (JAK3) binding domain does not mediate JAK3 association or activation in B-lymphoma or lymphoblastoid cell linesGeneration of specific cytotoxic T cells with a fragment of the Epstein-Barr virus-encoded p63/latent membrane protein.Epstein-Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1 alpha.Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor virusesRNAs induced by Epstein-Barr virus nuclear antigen 2 in lymphoblastoid cell lines.Epstein-Barr virus nuclear antigen 3C recruits histone deacetylase activity and associates with the corepressors mSin3A and NCoR in human B-cell lines.Epstein-Barr virus mRNAs produced by alternative splicingLatent infection membrane protein transmembrane FWLY is critical for intermolecular interaction, raft localization, and signaling.LMP1 transmembrane domain 1 and 2 (TM1-2) FWLY mediates intermolecular interactions with TM3-6 to activate NF-kappaBNucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: a probable transcriptional initiation siteAnalysis of EBNA-1 and LMP-1 variants in diseases associated with EBV infection in Chinese children.Epstein-Barr virus latent membrane protein-1 oncogene deletion in post-transplantation lymphoproliferative disordersEpstein-Barr virus LMP1 modulates the malignant potential of gastric carcinoma cells involving apoptosis.Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1.The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation; fibroblast cocultivation complements a critical function within the terminal 155 residues.An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP geneStimulation of NF-kappa B-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus.
P2860
Q24531838-65C20B31-DAAF-425F-BFB6-A4CD4B389DE2Q24561541-57DAF53F-E0C7-48AD-8AAE-9B09D1EA01D1Q24564305-4D0658A9-FA26-45F2-A8DA-6F3DBEF9EA94Q24644262-7E101606-4EC3-4272-8CBA-635EF1073F35Q26830643-16C7B698-4E4A-4ECA-816F-C53A81771E0BQ28731826-9CF25044-C84A-4616-8DF9-92B81B3A6826Q30403318-03FD1C12-FECC-4EC4-8541-70A7DF4BCF88Q33576126-EC365DA4-7BBE-4698-800A-526D0332EC3EQ33576708-BC916EDF-31FC-444C-BD9A-AADBC90DB796Q33643991-731C11E6-3BF6-4EDC-A98C-32EA59AD8467Q33646566-2D78C998-CCA8-44E0-B30D-5F998D55DA0EQ33688737-7435B45B-F988-4584-8ACE-B5AF83C02FA1Q33786551-2F9B8F3F-B228-4858-980A-6AAD3C4EAC3FQ33810690-90A33B15-04EF-4C78-A1B1-297A6A11895CQ33815241-EE107E59-E90D-42AE-8311-A7500A48B843Q33880494-4662E7FC-FEF6-4360-A08B-851B3A128329Q33880983-12A28E05-449D-4372-9720-DF7EFC35CD82Q33888498-4D7058D3-0AE0-448F-9876-8A2E8A2220C8Q33891606-B7508300-2AA3-4C9C-A3F5-507E88032925Q33905718-B44EF23D-FEF9-4490-8C0A-0316287B8180Q33937547-393924C2-37A5-4BA6-8179-7197E7665A35Q33937673-ABBFE25B-277C-4CE0-8B90-6D22CA19BE59Q34250209-C334AC8A-1199-4A37-8A3C-6D92EC276491Q34327176-2BD1CCA3-32A0-416C-917F-2FD40FAFA69DQ34334755-80510B37-2408-4193-B98C-7868A48C44E4Q34346992-AE78A764-DF8E-4E33-8B33-8ACE4233F064Q34394771-7A74426F-5584-4FB0-8076-FD979BEE2920Q34478739-9AA7AF3F-C830-4E49-889D-306B28C32657Q34782258-365569D7-1D2C-4CC7-AE1D-55583E0AEA22Q35051384-C7F34626-6182-47C7-9A1D-8BA175B2E679Q35122447-4EB52735-A8B0-45E3-A6A4-FC80154ABE84Q35139273-A131D443-BB98-467C-8FE5-ADB7591B7F9AQ35616566-AC1C0B8F-799F-494D-85B4-4F96950FC2F3Q35717137-A8AFF1C3-A27E-4887-A782-F1CF6B7F5174Q35763494-56D0B904-7CF0-46C4-A18B-AB2F23BECAAAQ35764233-A044B194-7DB9-4F40-A6BC-6CDA6FB4A692Q35829475-7FBB988D-1A12-435C-BE80-5E132B065506Q35831016-DB988DEB-4697-4907-B557-B3A94795FFD7Q35838226-8690D473-021D-4630-85D0-96D0E69F8421Q35838888-BD7B4493-697D-4B1D-9DBE-9779CC8035EE
P2860
Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Nucleotide sequence of an mRNA ...... may encode a membrane protein.
@en
type
label
Nucleotide sequence of an mRNA ...... may encode a membrane protein.
@en
prefLabel
Nucleotide sequence of an mRNA ...... may encode a membrane protein.
@en
P2860
P1433
P1476
Nucleotide sequence of an mRNA ...... may encode a membrane protein.
@en
P2093
S Fennewald
V van Santen
P2860
P304
P407
P577
1984-08-01T00:00:00Z